| Overview, prevention and management of chemotherapy extravasation FY Kreidieh, HA Moukadem, NS El Saghir World journal of clinical oncology 7 (1), 87, 2016 | 237 | 2016 |
| Global practice and efficiency of multidisciplinary tumor boards: results of an American Society of Clinical Oncology international survey NS El Saghir, RN Charara, FY Kreidieh, V Eaton, K Litvin, RA Farhat, ... Journal of global oncology 1 (2), 57-64, 2015 | 86 | 2015 |
| BRCA1 and BRCA2 Mutations in Ethnic Lebanese Arab Women With High Hereditary Risk Breast Cancer NS El Saghir, NK Zgheib, HA Assi, KE Khoury, Y Bidet, SM Jaber, ... The oncologist 20 (4), 357-364, 2015 | 67 | 2015 |
| Practice and impact of multidisciplinary tumor boards on patient management: a prospective study RN Charara, FY Kreidieh, RA Farhat, KA Al-Feghali, KE Khoury, A Haydar, ... Journal of global oncology 3 (3), 242-249, 2017 | 53 | 2017 |
| Circulating miRNA as biomarkers for colorectal cancer diagnosis and liver metastasis FJ Nassar, ZS Msheik, MM Itani, RE Helou, R Hadla, F Kreidieh, ... Diagnostics 11 (2), 341, 2021 | 40 | 2021 |
| Relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: an overview of prevention and treatment F Kreidieh, I Abou Dalle, N Moukalled, J El-Cheikh, E Brissot, M Mohty, ... International Journal of Hematology 116 (3), 330-340, 2022 | 36 | 2022 |
| Care of patients with hemoglobin disorders during the COVID‐19 pandemic: An overview of recommendations AT Taher, R Bou‐Fakhredin, F Kreidieh, I Motta, L De Franceschi, ... American Journal of Hematology 95 (8), E208, 2020 | 36 | 2020 |
| Hepatocellular carcinoma immunotherapy and the potential influence of gut microbiome S Temraz, F Nassar, F Kreidieh, D Mukherji, A Shamseddine, R Nasr International journal of molecular sciences 22 (15), 7800, 2021 | 32 | 2021 |
| The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition FY Kreidieh, HA Tawbi Therapeutic Advances in Medical Oncology 15, 17588359231186027, 2023 | 18 | 2023 |
| Anticoagulation for COVID-19 patients: a bird's-eye view F Kreidieh, S Temraz Clinical and Applied Thrombosis/Hemostasis 27, 10760296211039288, 2021 | 14 | 2021 |
| Understanding the phenotypic similarities between IFAP and Olmsted syndrome from a molecular perspective: the interaction of MBTPS2 and TRPV3 G Nemer, R Safi, F Kreidieh, J Usta, C Bergqvist, F Ballout, W Btadini, ... Archives of dermatological research 309, 637-643, 2017 | 14 | 2017 |
| A report on the education, employment and marital status of thalassemia patients from a tertiary care center in the Middle East R Bou-Fakhredin, NN Ghanem, F Kreidieh, R Tabbikha, H Daadaa, ... Hemoglobin 44 (4), 278-283, 2020 | 9 | 2020 |
| Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma S Temraz, R Nasr, D Mukherji, F Kreidieh, A Shamseddine Expert Review of Molecular Diagnostics 22 (5), 507-518, 2022 | 8 | 2022 |
| SARS-CoV-2 infected patient: from a hematologist’s perspective F Kreidieh, S Temraz Mediterranean Journal of Hematology and Infectious Diseases 12 (1), 2020 | 8 | 2020 |
| Management of locally advanced and metastatic breast cancer: guidelines, infrastructures and low resource settings NS El Saghir, FY Kreidieh, S El-Baba, BO Anderson Breast Cancer Management 5 (2), 69-77, 2016 | 8 | 2016 |
| Neoadjuvant immunotherapy in melanoma: the paradigm shift TJ Hieken, F Kreidieh, V Aedo-Lopez, MS Block, GA McArthur, RN Amaria American Society of Clinical Oncology Educational Book 43, e390614, 2023 | 7 | 2023 |
| Efficacy of adjuvant therapy in patients (pts) with AJCC v8 stage IIIA cutaneous melanoma. P Grover, I Li, A Kuijpers, FY Kreidieh, A Williamson, TMS Amaral, ... Journal of Clinical Oncology 41 (16_suppl), 9518-9518, 2023 | 5 | 2023 |
| Validity of 1% hormonal receptor positivity cutoff by the ASCO/college of American pathologists guidelines at the Georgia cancer center F Kreidieh, RF Sadek, LF Zhang, A Gopal, JP Blaize, D Yashar, R Patel, ... JCO Precision Oncology 6, e2100201, 2022 | 5 | 2022 |
| Prognostic significance of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase-1 (IDH-1) mutation in glioblastoma multiforme … Z Ayoub, F Geara, M Najjar, Y Comair, N Khoueiry-Zgheib, P Khoueiry, ... Clinical Neurology and Neurosurgery 182, 92-97, 2019 | 4 | 2019 |
| Current and emerging options for patients with melanoma brain metastases FY Kreidieh, HA Tawbi Clin Adv Hematol Oncol 20 (10), 2022 | 3 | 2022 |
Nagi El SaghirProfessor of Clinical Medicine, American University of Beirut在 aub.edu.lb 的电子邮件经过验证
